Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STOML2 promotes hepatocellular carcinoma cell proliferation, invasion and migration by activating the PI3K/AKT signaling pathway (Review). | Oncol Lett | 2026 | 41743019 | PubTator, text mining | PubMed |
| Benchmarking EGF signaling pathway inference using phosphoproteomics and kinase-substrate interactions. | Nat Commun | 2026 | 41741430 | PubTator, text mining | PubMed |
| Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma. | J Neurooncol | 2026 | 41739275 | PubTator, text mining | PubMed |
ROS disrupt COP9 signalosome-mediated ABCA1 protection and trigger its ubiquitination and degradation by cullin3 inhibiting cholesterol efflux and promoting foam cell formation in response to GPCR agonists. | Redox Biol | 2026 | 41722511 | PubTator, text mining | PubMed |
| Epithelial Gab1 Restricts Sepsis-Induced Intestinal Injury by Orchestrating TNF/NF-κB Axis. | Mediators Inflamm | 2026 | 41624377 | PubTator, text mining | PubMed |
| ONCOPLEX: an oncology-inspired hypergraph model integrating diverse biological knowledge for cancer driver gene prediction. | Sci Rep | 2026 | 41530500 | PubTator, text mining | PubMed |
| Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1. | Structure | 2026 | 41435833 | PubTator, text mining | PubMed |
| Post-Transcriptional Modification Integration for Ligand-Receptor Cellular Network Inference. | Mol Cell Proteomics | 2026 | 41423050 | PubTator, text mining | PubMed |
| Strategies for mitigating radiation damage and improving data completeness in 3D electron diffraction of protein crystals. | Acta Crystallogr D Struct Biol | 2026 | 41410349 | PubTator, text mining | PubMed |
| RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer. | Nat Cell Biol | 2026 | 41326795 | PubTator, text mining | PubMed |
| Molecular Insights into Fungal Glycosylphosphatidylinositol Transamidase Complex. | Adv Sci (Weinh) | 2026 | 41085069 | PubTator, text mining | PubMed |
| Research Trends and Insights Regarding MicroRNAs in Psoriasis: A Comprehensive Analysis. | Cureus | 2025 | 41458345 | PubTator, text mining | PubMed |
| MET signaling drives acquired resistance to erdafitinib in muscle-invasive bladder cancer cells. | Cell Death Dis | 2025 | 41315241 | PubTator, text mining | PubMed |
| PROS1/AXL signaling protects mice from lethal influenza infection by inducing M2 macrophage polarization. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 41158072 | PubTator, text mining | PubMed |
| Aberrant alternative splicing in alcoholic hepatitis: regulatory roles of RBPs and sQTLs. | BMC Gastroenterol | 2025 | 41087919 | PubTator, text mining | PubMed |
| The Colonic Crypt: Cellular Dynamics and Signaling Pathways in Homeostasis and Cancer. | Cells | 2025 | 41002393 | PubTator, text mining | PubMed |
| Selective EV Protein Sorting and Pathway Perturbation in AML Upon Synergistic FLT3 and Hedgehog Pathway Inhibition. | J Extracell Vesicles | 2025 | 40985884 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
| Silencing of PIGU inhibits the progression of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway. | Sci Rep | 2025 | 40854921 | PubTator, text mining | PubMed |
| Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infection. | Nat Microbiol | 2025 | 40739040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=2